> top > docs > PMC:7558914 > spans > 8728-10062 > annotations

PMC:7558914 / 8728-10062 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
187 40-48 Species denotes patients Tax:9606
188 116-124 Species denotes patients Tax:9606
189 168-176 Species denotes Patients Tax:9606
190 1112-1120 Species denotes patients Tax:9606
191 1222-1229 Species denotes patient Tax:9606
192 217-235 Chemical denotes hydroxychloroquine MESH:D006886
193 239-258 Chemical denotes lopinavir/ritonavir MESH:C558899
194 278-296 Chemical denotes hydroxychloroquine MESH:D006886
195 302-314 Chemical denotes azithromycin MESH:D017963
196 318-337 Chemical denotes lopinavir/ritonavir MESH:C558899
197 362-380 Chemical denotes hydroxychloroquine MESH:D006886
198 382-394 Chemical denotes azithromycin MESH:D017963
199 400-419 Chemical denotes lopinavir/ritonavir MESH:C558899
200 421-439 Chemical denotes Hydroxychloroquine MESH:D006886
201 486-505 Chemical denotes lopinavir/ritonavir MESH:C558899
202 650-662 Chemical denotes Azithromycin MESH:D017963
203 772-790 Chemical denotes hydroxychloroquine MESH:D006886
204 805-817 Chemical denotes azithromycin MESH:D017963
205 839-857 Chemical denotes hydroxychloroquine MESH:D006886
206 913-932 Chemical denotes lopinavir/ritonavir MESH:C558899
207 967-979 Chemical denotes azithromycin MESH:D017963
208 999-1010 Chemical denotes Chloroquine MESH:D002738
209 1071-1089 Chemical denotes hydroxychloroquine MESH:D006886
210 1150-1169 Chemical denotes lopinavir/ritonavir MESH:C558899
211 1204-1214 Chemical denotes remdesivir MESH:C000606551
212 65-84 Disease denotes respiratory illness MESH:D012140
213 157-166 Disease denotes pneumonia MESH:D011014

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T15 65-84 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T16 157-166 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T55 0-167 Sentence denotes Antiviral treatment was recommended for patients with mild upper respiratory illness with clinical risk factors and patients with mild, moderate, and severe pneumonia.
T56 168-420 Sentence denotes Patients could be treated with monotherapy using hydroxychloroquine or lopinavir/ritonavir; dual therapy with hydroxychloroquine plus azithromycin or lopinavir/ritonavir; or triple therapy with hydroxychloroquine, azithromycin, and lopinavir/ritonavir.
T57 421-649 Sentence denotes Hydroxychloroquine could be used in four different regimens, and lopinavir/ritonavir could be used in two different regimens, with varied dosages and duration of treatment—either a short (5-day) regimen or long (10-day) regimen.
T58 650-724 Sentence denotes Azithromycin was recommended at the same dosage and duration of treatment.
T59 725-818 Sentence denotes Protocols included the combination of all four hydroxychloroquine regimens with azithromycin.
T60 819-998 Sentence denotes Regimens 1 and 3 of hydroxychloroquine were combined in dual therapy with the two regimens of lopinavir/ritonavir, which in turn were combined with azithromycin in triple therapy.
T61 999-1108 Sentence denotes Chloroquine 500 mg twice per day was recommended as an alternative when hydroxychloroquine was not available.
T62 1109-1263 Sentence denotes In patients with three antiviral agents, lopinavir/ritonavir could be replaced with once-daily remdesivir if the patient was enrolled in a clinical trial.
T63 1264-1334 Sentence denotes The dosage and durations of antiviral treatments are shown in Table 1.